Alexion Pharmaceuticals Given "Outperform" Rating by Leerink Swann Analysts (ALXN)Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including …
Alexion is a great growth storyMarketWatchIs the stock still a good growth story, and is it currently trading at a reasonable price? By the way, the company is a $14.9 billion drug maker out of Cheshire, CT. They develop therapeutics to treat cancer, a…
Alexion Pharmaceuticals Share Price Target Raised to $84.00 by Barclays …Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the ther…
Robert W. Baird Analysts Upgrade Alexion Pharmaceuticals Shares to "Outperform …Web Inquirer… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those…
Artificial immune cell treatment for melanoma aims for human trials in 2013MedCity NewsNexImmune is an early stage biopharmaceutical company engineering artificial cells that can stimulate the immune system to treat cancer, transplant rejection, autoim…
Alexion Pharmaceuticals' CEO Discusses Q4 2011 Results – Earnings Call TranscriptSeeking AlphaWe're currently focused on clinical programs in four such disorders, acute humoral transplant rejection STEC-HUS, neuromyelitis optica and myasthenia …
Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor ConferenceSacramento BeeDr. Polvino will present an overview of the company and discuss top-line Phase 3 results of LCP-Tacro™, Veloxis' candidate to prevent organ transplan…
Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO & Investor ConferenceMarketWatch (press release)Dr. Polvino will present an overview of the company and discuss top-line Phase 3 results of LCP-Tacro(TM), Veloxis' candidate to prevent o…
IncellDx Announces the Expansion of HPV OncoTect® E6, E7 mRNA by Labco …EON: Enhanced Online News (press release)IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervica…
IncellDx Announces the Expansion of HPV OncoTect(R) E6, E7 mRNA by Labco …MarketWatch (press release)IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, bre…